On April 29, 2021, Brian Baker notified Turning Point Therapeutics, Inc. of his intention to resign from the Company and from his positions as principal financial officer and principal accounting officer, effective May 14, 2021, to pursue another opportunity. Effective as of May 14, 2021, Athena Countouriotis, the Company's President and Chief Executive Officer, will act as the Company's interim principal financial officer, and Kyri Van Hoose, the Company's Vice President, Accounting, will act as the Company's interim principal accounting officer, for the purposes of the Securities Exchange Act of 1934, as amended. Ms. Van Hoose joined the Company as Vice President, Accounting on May 5, 2021. Ms. Van Hoose previously served as chief financial officer of TEGA Therapeutics, Inc., a private biotechnology company, from September 2020 until May 2021.